Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

NCT: NCT03241420 · ACTIVE_NOT_RECRUITING

NCT IDNCT03241420
StatusACTIVE_NOT_RECRUITING
Start Date2017-04-24
Completion2030-12

Brief Summary

To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.

Frequently Asked Questions

What is Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease?

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease is a clinical trial registered under NCT03241420. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03241420?

The current status of NCT03241420 (Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease) is: ACTIVE_NOT_RECRUITING.

When did Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease start?

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease started on 2017-04-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑